Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talabostat in Metastatic Renal Cell Carcinoma
NCT00489710Phase 2Withdrawn
- Sponsor
- University of Nebraska
- Start
- Dec 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talabostat in renal cell carcinoma (RCC), sponsored by University of Nebraska. Planned start Dec 2006; status: withdrawn.
02
Drugs
talabostat
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00489710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489710.